Literature DB >> 29516470

Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 1.

Larry Charleston1, Jeffrey Royce2, Teshamae S Monteith3, Susan W Broner4, Hope L O'Brien5, Salvador L Manrriquez6, Matthew S Robbins7.   

Abstract

OBJECTIVE: To review the scope of the problem facing individuals with migraine who are under- or uninsured. In this first of a 2-part narrative review, we will explore migraine epidemiology and the challenges that face this vulnerable population.
BACKGROUND: Implementation of the Affordable Care Act has improved access to health care for many individuals who were previously uninsured, but there are many, particularly those of certain demographics, who are at high risk for worse outcomes.
METHODS: A narrative review was performed after a series of discussions within the Underserved Populations in Headache Medicine Special Interest Section meetings of the American Headache Society. Literature was reviewed for key concepts underpinning conceptual boundaries and a broad overview of the subject matter. Published guidelines, state-specific Medicaid websites, headache quality measurement set, literature review, and expert opinion were used to tailor suggested treatment options and therapeutic strategies.
RESULTS: Migraine is common, yet remains underdiagnosed and associated with worse outcomes among those of under-represented backgrounds and those who are underinsured or uninsured. Low socioeconomics may play an important role in the disease progression, characteristics, outcome, and quality of life of patients with migraine and other headache disorders. Other barriers to optimal care include time constraints, lack of access to specialty providers, transportation, and financial limitations.
CONCLUSION: There are many barriers and challenges that affect people with migraine who are underinsured or uninsured, particularly those of under-represented racial backgrounds and of lower socioeconomic status.
© 2018 American Headache Society.

Entities:  

Keywords:  headache; health disparities; migraine; treatments; underinsured; underserved; uninsured

Mesh:

Year:  2018        PMID: 29516470     DOI: 10.1111/head.13286

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  6 in total

Review 1.  A Review of Underserved and Vulnerable Populations in Headache Medicine in the United States: Challenges and Opportunities.

Authors:  Juliana H VanderPluym; Larry Charleston; Michael E Stitzer; Charles C Flippen; Cynthia E Armand; Jessica Kiarashi
Journal:  Curr Pain Headache Rep       Date:  2022-03-26

Review 2.  Equity and Disparities in Diagnosis, Management, and Research of Post-Traumatic Headache.

Authors:  Mejgan G Mukhtarzada; Teshamae S Monteith
Journal:  Curr Pain Headache Rep       Date:  2022-05-14

Review 3.  A Critical Exploration of Migraine as a Health Disparity: the Imperative of an Equity-Oriented, Intersectional Approach.

Authors:  Deanna R Befus; Megan Bennett Irby; Remy R Coeytaux; Donald B Penzien
Journal:  Curr Pain Headache Rep       Date:  2018-10-05

4.  Nonpharmacological Self-Management of Migraine Across Social Locations: An Equity-Oriented, Qualitative Analysis.

Authors:  Deanna R Befus; Sharon Hull; Justine Strand de Oliveira; Gillian Sanders Schmidler; Morris Weinberger; Remy R Coeytaux
Journal:  Glob Adv Health Med       Date:  2019-06-13

Review 5.  Factors Associated With, and Mitigation Strategies for, Health Care Disparities Faced by Patients With Headache Disorders.

Authors:  Jessica Kiarashi; Juliana VanderPluym; Christina L Szperka; Scott Turner; Mia T Minen; Susan Broner; Alexandra C Ross; Amanda E Wagstaff; Marissa Anto; Maya Marzouk; Teshamae S Monteith; Noah Rosen; Salvador L Manrriquez; Elizabeth Seng; Alan Finkel; Larry Charleston
Journal:  Neurology       Date:  2021-06-09       Impact factor: 11.800

6.  Chronic Noncancer Pain Management and Systemic Racism: Time to Move Toward Equal Care Standards.

Authors:  Malini Ghoshal; Hannah Shapiro; Knox Todd; Michael E Schatman
Journal:  J Pain Res       Date:  2020-11-06       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.